Envestnet Asset Management
TVTX icon

Envestnet Asset Management’s Travere Therapeutics TVTX Stock Holding History

Envestnet Asset Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Buy
51,552
+2,961
+6% +$131K ﹤0.01% 2867
2026
Q1 		$1.44M Sell
48,591
-1,509
-3% -$45.1K ﹤0.01% 3241
2025
Q4 		$1.91M Buy
+50,100
New +$1.63M ﹤0.01% 2861
2023
Q3 		– Sell
-10,695
Closed -$164K – 4160
2023
Q2 		$164K Buy
10,695
+734
+7% +$13.4K ﹤0.01% 3756
2023
Q1 		$224K Buy
+9,961
New +$212K ﹤0.01% 3602
2022
Q4 		– Sell
-10,025
Closed -$247K – 4068
2022
Q3 		$247K Buy
10,025
+136
+1% +$3.51K ﹤0.01% 3477
2022
Q2 		$240K Sell
9,889
-473
-5% -$11.9K ﹤0.01% 3483
2022
Q1 		$267K Buy
10,362
+1,224
+13% +$32.5K ﹤0.01% 3515
2021
Q4 		$284K Buy
9,138
+171
+2% +$4.82K ﹤0.01% 3454
2021
Q3 		$217K Buy
+8,967
New +$165K ﹤0.01% 3466
2020
Q2 		– Sell
-17,061
Closed -$249K – 3176
2020
Q1 		$249K Sell
17,061
-4,889
-22% -$73.6K ﹤0.01% 2636
2019
Q4 		$312K Buy
21,950
+1,781
+9% +$22.7K ﹤0.01% 2713
2019
Q3 		$234K Buy
20,169
+1,471
+8% +$24.3K ﹤0.01% 2794
2019
Q2 		$376K Buy
18,698
+592
+3% +$11.7K ﹤0.01% 2532
2019
Q1 		$410K Buy
+18,106
New +$400K ﹤0.01% 2461
2017
Q3 		– Sell
-127
Closed -$2K – 3037
2017
Q2 		$2K Sell
127
-9
-7% -$163 ﹤0.01% 2959
2017
Q1 		$3K Buy
136
+5
+4% +$98 ﹤0.01% 2976
2016
Q4 		$2K Buy
+131
New +$2.68K ﹤0.01% 2996

Other funds holding TVTX

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PIP
Palisades Investment Partners Santa Monica, California $352M AUM 76.79% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Envestnet Asset Management's TVTX Position: Q2 2026 in Review

Envestnet Asset Management increased its Travere Therapeutics (TVTX) stake by 6.1% in Q2 2026, buying an estimated $131K and bringing the position to 51,552 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2867.

Envestnet Asset Management first reported a position in TVTX in Q4 2016 and has held it in 18 quarters since. 82 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Envestnet Asset Management held 51,552 shares of Travere Therapeutics worth $2.93M as of Q2 2026.
  • Envestnet Asset Management bought 2,961 Travere Therapeutics shares in Q2 2026, an estimated $131K.
  • Travere Therapeutics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2867 holding.
  • Envestnet Asset Management first reported a position in Travere Therapeutics in Q4 2016 and has held it in 18 quarters since.
  • 82 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.